Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Lauren Clark

From the lab to clinical trials – why a preventative lung cancer vaccine could soon be a reality

Cancer Researchers work in the labs at the Crick Institute in London
Cancer researchers work in the lab. Photograph: Jane Stockdale/Cancer Research UK

Whether you have been touched by the effects of lung cancer or not, there are some hard truths you may already know about it. According to the NHS, more than 43,000 people are diagnosed with the disease every year – making it the third most common cancer in the UK. Worse still, it kills around 33,000 people annually, with only around one in 10 people surviving for 10 years or more after diagnosis. Lung cancer often hides in plain sight, with symptoms appearing late, when treatment options are limited. But this could all be about to change.

Thanks to scientific advances, we’re entering a new era when it comes to tackling lung cancer. Researchers are now preparing to begin clinical trials of a preventive vaccine that could reduce the risk of developing the disease. It’s been made possible with funding from Cancer Research UK, the world’s largest charitable funder of cancer research, whose research has already helped double cancer survival in the UK over the past 50 years.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.